Adial pharmaceuticals completes private placement of common stock at $4.00 per share

Charlottesville, va., dec. 22, 2021 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has received the balance of $720,000 due from the $800,000 private placement previously disclosed by the company on november 10, 2021 (the “offering”). the shares of common stock sold in the offering were priced at $4.00 per share and a total of 200,000 shares (the “shares”) were purchased in the offering. the offering was fully subscribed.
ADIL Ratings Summary
ADIL Quant Ranking